What Does the Democratic Sweep Mean for US Cannabis?
Last week’s US midterm elections have transformed the political map of the country, handing both the House and the Senate over to the Democrats.
Last week’s US midterm elections have transformed the political map of the country, handing both the House and the Senate over to the Democrats.
After closing the Agential Cannabis conference in Bangkok last month, Stephen Murphy, founder and CEO of Prohibition Partners, considers how medicinal cannabis in the Asia-Pacific region is taking shape and what will determine leadership in the region over the next five years.
Why are cannabis listings so relevant in 2026?
North American institutional cannabis investors now see the European medical market as a crucial driver of growth, a new survey suggests.
Is cannabis legal in Spain? No, not on paper, and in practice it remains a grey area.
The Global Cannabis Regulatory Summit (GCRS) has published a 100-page white paper that diagnoses a fragmented global regulatory landscape and sets out a working architecture to address it.
Government-led scientific studies from across Europe’s most progressive cannabis markets are solidifying an evidence base suggesting that greater access does not cause greater harm to public health.
Initial findings from the Netherlands’ landmark ‘controlled cannabis supply chain experiment’ were submitted to the House of Representatives on September 9, the first published findings since the T0 baseline report, published in March 2024 (covering data collected in 2022).
In the UK, cannabis remains a Class B drug under the Misuse of Drugs Act 1971, meaning the possession, supply and cultivation for recreational purposes are all criminal offences carrying significant potential sentences.